EVG Evgen Pharma Plc

 

TIDMEVG 
 
RNS Number : 8249U 
Evolution Group PLC 
01 July 2009 
 

Embargoed until 7.00am 1 July 2009 
The Evolution Group Plc 
(the "Evolution Group", the "Group", the "Company") 
Trading update 
 
 
Evolution Group, the listed investment bank and private client investment 
management group, makes the following trading update. 
 
 
Group performance 
 
 
In line with the announcement of our interim management statement on the 19 May 
2009, the Group continues to perform well. The expansion of our institutional 
equities business is proceeding according to plan, with the successful 
integration of our recent new hires.  Our fixed income capabilities are also 
making good progress with continued growth in products and customers. Our 
private client business, Williams de Broë, continues to see momentum with net 
inflows in line with expectations. 
 
 
Financial position 
 
 
The Group's financial position continues to be strong and the maintenance of a 
strong and liquid balance sheet remains a core Group policy. 
 
 
Notes 
 
 
Half Year results 
 
 
The Group entered a close period from the end of  its Half Year on 30 June 2009 
until the publication of its Half Year results to 30 June 2009 on or before 31 
August 2009 
 
 
Forward looking statements 
 
 
This trading update may contain forward-looking statements with respect to the 
financial condition, results, operations and businesses of The Evolution Group 
plc. Such statements and forecasts involve risk and uncertainty because they 
relate to events and depend upon circumstances that will occur in the future. 
There are a number of factors that could cause actual results or developments to 
differ materially from those expressed or implied by forward-looking statements 
and forecasts. Forward-looking statements and forecasts are based on the 
Directors' current view and information known to them at the date of this 
statement. The Directors do not make any undertaking to update or revise any 
forward-looking statements, whether as a result of new information, future 
events or otherwise. Nothing in this statement should be construed as a profit 
forecast. 
 
-Ends- 
For further information, please contact: 
 
 
+---------------------------------------------------+------------------------+ 
| The Evolution Group Plc                           |          020 7071 4300 | 
| Alex Snow, Chief Executive Officer                |                        | 
| Andrew Westenberger, Finance Director             |                        | 
+---------------------------------------------------+------------------------+ 
|                                                   |                        | 
+---------------------------------------------------+------------------------+ 
| Bell Pottinger Corporate and Financial            |          020 7861 3232 | 
| Charles Cook                                      |                        | 
| Emma Kent                                         |                        | 
| Victoria Geoghegan                                |                        | 
+---------------------------------------------------+------------------------+ 
 
 
Notes to Editors: 
 
 
The Evolution Group Plc 
 
 
The Evolution Group is the holding company of Evolution Securities Limited, 
Williams de Broë Limited and WDB Capital Limited. Founded in April 2001 and 
originally listed on AIM, the Evolution Group joined the Official List in 2003 
and now has a market capitalisation of over GBP300 million. 
 
 
Evolution Securities Limited is a leading investment bank focused on mid-cap UK 
public companies. It provides a full range of investment banking services 
including equity research, institutional sales and trading, market making, fixed 
income and corporate finance advice. Evolution Securities Limited has over 75 
retained corporate clients. It is authorised and regulated by the Financial 
Services Authority. 
 
 
Williams de Broë Limited is a leading private client investment manager, with 
offices in Bath, Birmingham, Bournemouth, Edinburgh, Exeter, Guildford and 
London. Williams de Broë is authorised and regulated by the Financial Services 
Authority. 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 TSTBSGDLLSXGGCG 
 

Grafico Azioni Evgen Pharma (LSE:EVG)
Storico
Da Giu 2024 a Lug 2024

Grafico Azioni Evgen Pharma (LSE:EVG)
Storico
Da Lug 2023 a Lug 2024